According to BIS Research, CRISPR technology is a tool for gene editing. It allows to alter the DNA sequences and modify gene function. Potential applications of the CRISPR technology include correction of genetic defects, treatment and prevention of the spread of diseases, and improvement in crops. The CRISPR technology is a highly programmable, rapid diagnostic tool expected to disrupt the COVID-19 diagnostic market, which is currently dominated by PCR-based testing. However, its promise also raises ethical concerns in human genome editing process, which is referred to a process of making genetic modifications to human embryos and reproductive cells. With several companies eagerly competing to establish dominance in the global CRISPR gene editing market, there have been a large number of highly emerging and dynamic companies that have undertaken significant activities to establish their position in the market. Although these companies are currently far behind the market leaders...